241. O'Donnell DE, Revill SM, Webb KA.

Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary

disease. Am J Respir Crit Care Med 2001; 164(5): 770-7.
242. Casaburi R, Maltais F, Porszasz J, et al. Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to
moderate chronic obstructive pulmonary disease. Ann Am Thorac Soc 2014; 11(9): 1351-61.
243. Rodriguez-Roisin R, Drakulovic M, Rodriguez DA, Roca J, Barbera JA, Wagner PD. Ventilation-perfusion imbalance and
chronic obstructive pulmonary disease staging severity. J Appl Physiol (1985) 2009; 106(6): 1902-8.
244. Sakao S, Voelkel NF, Tatsumi K. The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations.
Eur Respir Rev 2014; 23(133): 350-5.
245. Iyer KS, Newell JD, Jr., Jin D, et al. Quantitative Dual-Energy Computed Tomography Supports a Vascular Etiology of
Smoking-induced Inflammatory Lung Disease. Am J Respir Crit Care Med 2016; 193(6): 652-61.
246. Alford SK, van Beek EJ, McLennan G, Hoffman EA. Heterogeneity of pulmonary perfusion as a mechanistic image-based
phenotype in emphysema susceptible smokers. Proc Natl Acad Sci U S A 2010; 107(16): 7485-90.
247. Peinado VI, Pizarro S, Barbera JA. Pulmonary vascular involvement in COPD. Chest 2008; 134(4): 808-14.
248. Kovacs G, Agusti A, Barbera JA, et al. Pulmonary Vascular Involvement in Chronic Obstructive Pulmonary Disease. Is
There a Pulmonary Vascular Phenotype? Am J Respir Crit Care Med 2018; 198(8): 1000-11.
249. Zhang L, Liu Y, Zhao S, et al. The Incidence and Prevalence of Pulmonary Hypertension in the COPD Population: A
Systematic Review and Meta-Analysis. Int J Chron Obstruct Pulmon Dis 2022; 17: 1365-79.
250. Kovacs G, Avian A, Bachmaier G, et al. Severe Pulmonary Hypertension in COPD: Impact on Survival and Diagnostic
Approach. Chest 2022; 162(1): 202-12.
251. Wells JM, Washko GR, Han MK, et al. Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med

TE
2012; 367(10): 913-21.
252. Parker CM, Voduc N, Aaron SD, Webb KA, O'Donnell DE. Physiological changes during symptom recovery from

U
IB
moderate exacerbations of COPD. Eur Respir J 2005; 26(3): 420-8.

TR
253. Barbera JA, Roca J, Ferrer A, et al. Mechanisms of worsening gas exchange during acute exacerbations of chronic

IS
obstructive pulmonary disease. Eur Respir J 1997; 10(6): 1285-91.

D
254. Celli BR, Fabbri LM, Aaron SD, et al. An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary

R
O
Disease Exacerbations: The Rome Proposal. Am J Respir Crit Care Med 2021; 204(11): 1251-8.
PY
255. Miller J, Edwards LD, Agusti A, et al. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir
O

Med 2013; 107(9): 1376-84.

C

256. Dharmage S, Agusti A. Personal communication. 2022.

T
O

257. Stolz D, Mkorombindo T, Schumann DM, et al. Towards the elimination of chronic obstructive pulmonary disease: a
N

Lancet Commission. Lancet 2022; 400(10356): 921-72.

O
-D
LS
IA
ER
AT
M
T
H
IG
R
PY
O
C

27